(CVX) Chevron - Ratings and Ratios
Exchange: NYSE •
Country: United States •
Currency: USD •
Type: Common Stock •
ISIN: US1667641005
Crude, Gasoline, Diesel, Jet, Chemicals
Dividends
| Dividend Yield | 4.60% |
| Yield on Cost 5y | 9.06% |
| Yield CAGR 5y | 6.02% |
| Payout Consistency | 82.0% |
| Payout Ratio | 87.0% |
| Risk via 10d forecast | |
|---|---|
| Volatility | 20.9% |
| Value at Risk 5%th | 35.1% |
| Relative Tail Risk | 2.01% |
| Reward TTM | |
|---|---|
| Sharpe Ratio | -0.14 |
| Alpha | -12.19 |
| CAGR/Max DD | -0.01 |
| Character TTM | |
|---|---|
| Hurst Exponent | 0.479 |
| Beta | 0.648 |
| Beta Downside | 1.057 |
| Drawdowns 3y | |
|---|---|
| Max DD | 22.26% |
| Mean DD | 12.20% |
| Median DD | 12.12% |
Description: CVX Chevron December 02, 2025
Chelsea Corporation (NYSE: CVX) is a vertically integrated energy and chemicals company operating globally, with two primary business segments: Upstream, which covers exploration, development, production, and transportation of crude oil, natural gas, LNG, and carbon capture projects; and Downstream, which refines crude into fuels, markets petroleum products and lubricants, produces renewable fuels, and manufactures petrochemicals and plastics.
As of Q2 2024, Chevron reported upstream production of approximately 3.1 million barrels of oil equivalent per day and a downstream refining margin of $13 per barrel, contributing to a net income of $6.6 billion and free cash flow exceeding $9 billion. The company’s capital allocation includes roughly $10 billion in annual spending, with a focus on expanding LNG liquefaction capacity and advancing its low-carbon initiatives, while maintaining a dividend yield near 4.5 %.
Key sector drivers affecting Chevron include global oil price volatility tied to OPEC+ output decisions, accelerating demand for LNG in Asia-Europe markets, and increasing regulatory pressure on carbon emissions that incentivizes investment in carbon capture and renewable fuel production.
For a deeper dive into Chevron’s valuation metrics and scenario analysis, check the ValueRay platform.
Piotroski VR‑10 (Strict, 0-10) 4.0
| Net Income (12.78b TTM) > 0 and > 6% of Revenue (6% = 11.31b TTM) |
| FCFTA 0.05 (>2.0%) and ΔFCFTA -2.70pp (YES ≥ +1.0pp, WARN ≥ +0.5pp) |
| NWC/Revenue 2.86% (prev 1.27%; Δ 1.59pp) (YES ≤20% & Δ≤-1pp; WARN ≤25% & Δ≤0 oder ≤40% & Δ≤-3pp) |
| CFO/TA 0.10 (>3.0%) and CFO 31.70b > Net Income 12.78b (YES >=105%, WARN >=100%) |
| Net Debt (33.82b) to EBITDA (41.68b) ratio: 0.81 <= 3.0 (WARN <= 3.5) |
| Current Ratio 1.15 (target 1.5–3.0; WARN 1.2–<1.5 or >3.0–5.0; CFO/TA gate active) |
| Outstanding Shares last Quarter (1.81b) change vs 12m ago 0.05% (target <= -2.0% for YES) |
| Gross Margin 18.79% (prev 29.85%; Δ -11.06pp) >=18% & Δ>=+0.5pp (WARN >=15% & Δ>=0) |
| Asset Turnover 64.36% (prev 74.84%; Δ -10.48pp) >=50% & Δ>=+2pp (WARN >=35% & Δ>=0) |
| Interest Coverage Ratio 21.10 (EBITDA TTM 41.68b / Interest Expense TTM 1.05b) >= 6 (WARN >= 3) |
Altman Z'' 4.32
| (A) 0.02 = (Total Current Assets 40.87b - Total Current Liabilities 35.47b) / Total Assets 326.50b |
| (B) 0.63 = Retained Earnings (Balance) 206.01b / Total Assets 326.50b |
| (C) 0.08 = EBIT TTM 22.26b / Avg Total Assets 292.87b |
| (D) 1.57 = Book Value of Equity 205.25b / Total Liabilities 130.90b |
| Total Rating: 4.32 = (6.56 * A) + (3.26 * B) + (6.72 * C) + (1.05 * D) |
ValueRay F-Score (Strict, 0-100) 50.89
| 1. Piotroski 4.0pt |
| 2. FCF Yield 4.51% |
| 3. FCF Margin 8.04% |
| 4. Debt/Equity 0.22 |
| 5. Debt/Ebitda 0.81 |
| 6. ROIC - WACC (= 0.34)% |
| 7. RoE 8.01% |
| 8. Rev. Trend -52.71% |
| 9. EPS Trend -79.91% |
What is the price of CVX shares?
As of December 09, 2025, the stock is trading at USD 148.71 with a total of 10,236,659 shares traded.
Over the past week, the price has changed by -2.51%, over one month by -3.39%, over three months by -2.36% and over the past year by -0.94%.
Over the past week, the price has changed by -2.51%, over one month by -3.39%, over three months by -2.36% and over the past year by -0.94%.
Is CVX a buy, sell or hold?
Chevron has received a consensus analysts rating of 3.88.
Therefore, it is recommended to buy CVX.
- Strong Buy: 9
- Buy: 6
- Hold: 9
- Sell: 0
- Strong Sell: 1
What are the forecasts/targets for the CVX price?
| Issuer | Target | Up/Down from current |
|---|---|---|
| Wallstreet Target Price | 172.7 | 16.1% |
| Analysts Target Price | 172.7 | 16.1% |
| ValueRay Target Price | 152 | 2.2% |
CVX Fundamental Data Overview December 06, 2025
Market Cap USD = 302.22b (302.22b USD * 1.0 USD.USD)
P/E Trailing = 21.097
P/E Forward = 19.2308
P/S = 1.6017
P/B = 1.5965
P/EG = 2.911
Beta = 0.673
Revenue TTM = 188.49b USD
EBIT TTM = 22.26b USD
EBITDA TTM = 41.68b USD
Long Term Debt = 37.95b USD (from longTermDebt, last quarter)
Short Term Debt = 3.59b USD (from shortTermDebt, last quarter)
Debt = 41.54b USD (from shortLongTermDebtTotal, last quarter)
Net Debt = 33.82b USD (from netDebt column, last quarter)
Enterprise Value = 336.04b USD (302.22b + Debt 41.54b - CCE 7.72b)
Interest Coverage Ratio = 21.10 (Ebit TTM 22.26b / Interest Expense TTM 1.05b)
FCF Yield = 4.51% (FCF TTM 15.16b / Enterprise Value 336.04b)
FCF Margin = 8.04% (FCF TTM 15.16b / Revenue TTM 188.49b)
Net Margin = 6.78% (Net Income TTM 12.78b / Revenue TTM 188.49b)
Gross Margin = 18.79% ((Revenue TTM 188.49b - Cost of Revenue TTM 153.07b) / Revenue TTM)
Gross Margin QoQ = 11.57% (prev 11.89%)
Tobins Q-Ratio = 1.03 (Enterprise Value 336.04b / Total Assets 326.50b)
Interest Expense / Debt = 0.89% (Interest Expense 370.0m / Debt 41.54b)
Taxrate = 33.27% (1.80b / 5.41b)
NOPAT = 14.85b (EBIT 22.26b * (1 - 33.27%))
Current Ratio = 1.15 (Total Current Assets 40.87b / Total Current Liabilities 35.47b)
Debt / Equity = 0.22 (Debt 41.54b / totalStockholderEquity, last quarter 189.84b)
Debt / EBITDA = 0.81 (Net Debt 33.82b / EBITDA 41.68b)
Debt / FCF = 2.23 (Net Debt 33.82b / FCF TTM 15.16b)
Total Stockholder Equity = 159.46b (last 4 quarters mean from totalStockholderEquity)
RoA = 3.91% (Net Income 12.78b / Total Assets 326.50b)
RoE = 8.01% (Net Income TTM 12.78b / Total Stockholder Equity 159.46b)
RoCE = 11.28% (EBIT 22.26b / Capital Employed (Equity 159.46b + L.T.Debt 37.95b))
RoIC = 7.79% (NOPAT 14.85b / Invested Capital 190.61b)
WACC = 7.46% (E(302.22b)/V(343.77b) * Re(8.40%) + D(41.54b)/V(343.77b) * Rd(0.89%) * (1-Tc(0.33)))
Discount Rate = 8.40% (= CAPM, Blume Beta Adj.)
Shares Correlation 3-Years: -33.33 | Cagr: -1.62%
[DCF Debug] Terminal Value 73.65% ; FCFE base≈16.70b ; Y1≈13.73b ; Y5≈9.83b
Fair Price DCF = 85.10 (DCF Value 170.15b / Shares Outstanding 2.00b; 5y FCF grow -21.46% → 3.0% )
EPS Correlation: -79.91 | EPS CAGR: -8.30% | SUE: 0.51 | # QB: 0
Revenue Correlation: -52.71 | Revenue CAGR: 1.32% | SUE: 0.22 | # QB: 0
EPS next Quarter (2026-03-31): EPS=1.81 | Chg30d=+0.013 | Revisions Net=+3 | Analysts=18
EPS next Year (2026-12-31): EPS=7.82 | Chg30d=-0.324 | Revisions Net=-2 | Growth EPS=+6.2% | Growth Revenue=+2.3%
P/E Trailing = 21.097
P/E Forward = 19.2308
P/S = 1.6017
P/B = 1.5965
P/EG = 2.911
Beta = 0.673
Revenue TTM = 188.49b USD
EBIT TTM = 22.26b USD
EBITDA TTM = 41.68b USD
Long Term Debt = 37.95b USD (from longTermDebt, last quarter)
Short Term Debt = 3.59b USD (from shortTermDebt, last quarter)
Debt = 41.54b USD (from shortLongTermDebtTotal, last quarter)
Net Debt = 33.82b USD (from netDebt column, last quarter)
Enterprise Value = 336.04b USD (302.22b + Debt 41.54b - CCE 7.72b)
Interest Coverage Ratio = 21.10 (Ebit TTM 22.26b / Interest Expense TTM 1.05b)
FCF Yield = 4.51% (FCF TTM 15.16b / Enterprise Value 336.04b)
FCF Margin = 8.04% (FCF TTM 15.16b / Revenue TTM 188.49b)
Net Margin = 6.78% (Net Income TTM 12.78b / Revenue TTM 188.49b)
Gross Margin = 18.79% ((Revenue TTM 188.49b - Cost of Revenue TTM 153.07b) / Revenue TTM)
Gross Margin QoQ = 11.57% (prev 11.89%)
Tobins Q-Ratio = 1.03 (Enterprise Value 336.04b / Total Assets 326.50b)
Interest Expense / Debt = 0.89% (Interest Expense 370.0m / Debt 41.54b)
Taxrate = 33.27% (1.80b / 5.41b)
NOPAT = 14.85b (EBIT 22.26b * (1 - 33.27%))
Current Ratio = 1.15 (Total Current Assets 40.87b / Total Current Liabilities 35.47b)
Debt / Equity = 0.22 (Debt 41.54b / totalStockholderEquity, last quarter 189.84b)
Debt / EBITDA = 0.81 (Net Debt 33.82b / EBITDA 41.68b)
Debt / FCF = 2.23 (Net Debt 33.82b / FCF TTM 15.16b)
Total Stockholder Equity = 159.46b (last 4 quarters mean from totalStockholderEquity)
RoA = 3.91% (Net Income 12.78b / Total Assets 326.50b)
RoE = 8.01% (Net Income TTM 12.78b / Total Stockholder Equity 159.46b)
RoCE = 11.28% (EBIT 22.26b / Capital Employed (Equity 159.46b + L.T.Debt 37.95b))
RoIC = 7.79% (NOPAT 14.85b / Invested Capital 190.61b)
WACC = 7.46% (E(302.22b)/V(343.77b) * Re(8.40%) + D(41.54b)/V(343.77b) * Rd(0.89%) * (1-Tc(0.33)))
Discount Rate = 8.40% (= CAPM, Blume Beta Adj.)
Shares Correlation 3-Years: -33.33 | Cagr: -1.62%
[DCF Debug] Terminal Value 73.65% ; FCFE base≈16.70b ; Y1≈13.73b ; Y5≈9.83b
Fair Price DCF = 85.10 (DCF Value 170.15b / Shares Outstanding 2.00b; 5y FCF grow -21.46% → 3.0% )
EPS Correlation: -79.91 | EPS CAGR: -8.30% | SUE: 0.51 | # QB: 0
Revenue Correlation: -52.71 | Revenue CAGR: 1.32% | SUE: 0.22 | # QB: 0
EPS next Quarter (2026-03-31): EPS=1.81 | Chg30d=+0.013 | Revisions Net=+3 | Analysts=18
EPS next Year (2026-12-31): EPS=7.82 | Chg30d=-0.324 | Revisions Net=-2 | Growth EPS=+6.2% | Growth Revenue=+2.3%
Additional Sources for CVX Stock
News:
Wall Street Journal |
Benzinga |
Yahoo Finance
Tweets: X | Stocktwits
Fund Manager Positions: Dataroma | Stockcircle
Tweets: X | Stocktwits
Fund Manager Positions: Dataroma | Stockcircle